{"disease":{"id":"visual-outcome","name":"visual outcome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03062085","title":"Shanghai High Myopia Study","phase":"","overall_status":"RECRUITING","enrollment_count":60000,"lead_sponsor_name":"Shanghai High Myopia Study Group","has_results":false},{"nct_id":"NCT03063216","title":"Shanghai Pediatric Cataract Study","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Evidence Based Cataract Study Group","has_results":false},{"nct_id":"NCT06590272","title":"Comparison on Outcomes of Four IOLs in Patients With Cataracts","phase":"","overall_status":"COMPLETED","enrollment_count":103,"lead_sponsor_name":"Shanghai 10th People's Hospital","has_results":false},{"nct_id":"NCT05626478","title":"Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Nicole Fram M.D.","has_results":false},{"nct_id":"NCT00758940","title":"Clinical Assessment of Visual Function With the Acrysof ReSTOR Multifocal IOL","phase":"PHASE4","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Alcon Research","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}